Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment
EXTRA 研究在接受阿法替尼一线治疗的老年 EGFR 突变型肺癌患者中的疗效和安全性结果
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-38944-3
Morikawa, Kei; Takata, Saori; Tanaka, Hisashi; Itani, Hidetoshi; Ishihara, Masashi; Horiuchi, Kazuya; Kato, Yasuhiro; Ikemura, Shinnosuke; Nakagawa, Hideyuki; Nakahara, Yoshiro; Seki, Yoshitaka; Bessho, Akihiro; Takahashi, Nobumasa; Hayashi, Kentaro; Endoh, Takeo; Takeyama, Kiyoshi; Maekura, Toshiya; Takigawa, Nagio; Kawase, Akikazu; Endoh, Makoto; Nemoto, Kenji; Kishi, Kazuma; Soejima, Kenzo; Okuma, Yusuke; Yoshimura, Kenichi; Saigusa, Daisuke; Kanai, Yae; Ueda, Koji; Togashi, Akira; Matsutani, Noriyuki; Seki, Nobuhiko